Our purpose forfurther studies is to make use of TPT with pifithrinor inhibitors of p53 as a co-treatment after irradiationwith X-6MV to enhance tumor radiosensitizationto TPT and then evaluate the combined effectsof these agents on the cells. This evidence concerns the gene TP53 and neoplasm.